{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T22:29:01Z","timestamp":1699482541400},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.anndiagpath.2011.04.010","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T03:35:31Z","timestamp":1313379331000},"page":"515-520","source":"Crossref","is-referenced-by-count":5,"title":["A patient with prostate cancer and multiple myeloma\u2014diagnostics and possible association of both diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"Mirna","family":"Su\u010di\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Bi\u0161of","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"\u010ca\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanda Ba\u0161i\u0107","family":"Kinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Kolenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nives","family":"Ljubi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tena","family":"Su\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Poto\u010dki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0005","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/cncr.11635","article-title":"Prostate carcinoma presentation, diagnosis, and staging: an update forms the National Cancer Data Base","volume":"98","author":"Miller","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ucl.2009.11.006","article-title":"Blood and tissue biomarkers in prostate cancer: state of the art","volume":"37","author":"Fiorentino","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","article-title":"Histology grading of prostate cancer: a perspective","volume":"23","author":"Gleason","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/10937400701873548","article-title":"Role of hormonal and other factors in human prostate cancer","volume":"11","author":"Wigle","year":"2008","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0025","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"200","article-title":"Plasma cell neoplasms","author":"McKenna","year":"2008"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1054\/bjoc.2001.1998","article-title":"Second primary neoplasms among 53,159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a case search for common mechanisms","volume":"85","author":"Dong","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0210-4806(07)73614-8","article-title":"Prostate adenocarcinoma and synchronous multiple myeloma: a case report","volume":"31","author":"P\u00e9rez L\u00f3pez","year":"2007","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0050","first-page":"725","article-title":"Association of multiple myeloma and solid neoplasms: analysis of 13 cases","volume":"199","author":"Todol\u00ed Parra","year":"1999","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0055","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/jnci\/93.19.1479","article-title":"Familial multiple myeloma: a family study and review of the literature","volume":"93","author":"Lynch","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jnci\/djp533","article-title":"Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam","volume":"102","author":"Wever","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/gcc.20560","article-title":"Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate","volume":"47","author":"Bettendorf","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-1596-1-4","article-title":"Prognostic factors in prostate cancer","volume":"1","author":"Buhmeida","year":"2006","journal-title":"Diagn Path"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.juro.2010.09.099","article-title":"Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy","volume":"185","author":"Stone","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0080","first-page":"3275","article-title":"Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas","volume":"63","author":"Nzula","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0085","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2353\/ajpath.2009.080879","article-title":"Immunoglobulin expression in non-lymphoid lineage and neoplastic cells","volume":"174","author":"Chen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.mehy.2003.10.029","article-title":"Is there an association between multiple myeloma and prostate cancer?","volume":"63","author":"Kao","year":"2004","journal-title":"Med Hypothesis"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3324\/haematol.2009.006346","article-title":"Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Hematologica"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/hmg\/ddi144","article-title":"Common chromosomal fragile site FRA16D mutation in cancer cells","volume":"14","author":"Finnis","year":"2005","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0115","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1038\/sj.onc.1207474","article-title":"Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer","volume":"23","author":"Watson","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/30012","article-title":"Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells","volume":"393","author":"Qiu","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0125","first-page":"1882","article-title":"Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting","volume":"6","author":"Borre","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2011.04.010_bb0130","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913411000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913411000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T13:59:04Z","timestamp":1543586344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913411000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1092913411000815"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2011.04.010","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}